Founding Ochre Bio: A Fireside Chat with Jack O'Meara

​Introducing Cell to Scale - A New Event Series Spotlighting the Journeys of Founders Behind Groundbreaking Biotechnology Companies, Hosted by One of Europe's Most Prominent Biotech Investors, Nadav Rosenberg.

​Kicking off the series, our inaugural event will feature Jack O'Meara, co-founder of Ochre Bio.

Jack founded Ochre Bio to develop RNA therapies for chronic liver diseases. Since its founding at Entrepreneur First in 2019, Ochre Bio has raised $40 million from leading investors, including Khosla Ventures, and secured $1 bn+ in partnerships with European pharmaceutical companies Boehringer Ingelheim and GSK. In this fireside chat, Jack will share key lessons from building Ochre Bio and his perspective on the next frontiers of biotechnology.

​Hosting the series will be Nadav Rosenberg, founder of Saras Capital, a Biotechnology-focused fund in London, and Venture Partner at Entrepreneur First. With a portfolio that includes pioneering companies like Ochre Bio, Core Biogenesis, and Eleven Therapeutics, Nadav’s focus is on backing ambitious scientists at the earliest stages of their founding journeys.

We look forward to seeing you there!

Agenda:

18:30-19:00: Registration
19:00-20:00: Fireside Chat with Jack O'Meara
20:00-21:00: Networking and Refreshments